Pressmeddelanden

REG
The Board of Directors of Eevia Health Plc has today resolved on a rights issue of approximately SEK 12.1 million, for which the intention was announced on 30 December 2024 THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS NOT INTENDED TO BE PUBLISHED, DISCLOSED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KON...
REG
COMMUNIQUE FROM THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS IN EEVIA HEALTH PLC The Extraordinary General Meeting of Shareholders of Eevia Health Plc, corp. reg. no 2825194-4 (the "Company") was held on January 17, 2024, in Seinäjoki, Finland, whereby the sh...
REG MAR
Eevia Health plans to divest its berry-manufacturing-related assets, providing compensation shares as dividends to Eevia's shareholders Eevia Health Plc ("Eevia" or "The Company") is planning to divest business assets for 2.5 - 3.0 MEUR related to the manufacturing of berry-based ingredients. The aim is to protec...
REG MAR
Eevia Health Plc plans divesting assets to an eye-health start-up and provide compensation shares as dividends to its shareholder Eevia Health Plc ("Eevia" or "The Company") is planning to divest business assets related to Retinari™, a prospective eye health compound with auspicious pre-clinical results for...
Eevia Health Plc gears towards a gut health offering with external support Eevia Health Plc ("Eevia" or "The Company") is planning further to support its turnaround plan with external turnaround experts to improve focus on revenue generation and the str...
Eevia Health Plc receives approval for its top bilberry extract from an old customer and the first new order in 18 months of c. 572 KSEK (50 KEUR) Eevia Health Plc ("Eevia" or "The Company") has received approval of a second product from an old US nutraceutical customer and received a new 50 KEUR (572 KSEK) sales order. The...
Visa fler pressmeddelanden

Rapporter

Video

Finansiell kalender

Bokslutskommuniké 2024 Bokslutskommuniké
Delårsrapport Q1 2025 Delårsrapport
Delårsrapport Q2 2025 Delårsrapport

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.

Webbplats
eeviahealth.com/investors

Handelsinformation

Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658

IR-Kontakt

Stein Ulve IR-kontakt [email protected]